Clinical Research

Neuralink users reveal power to move robotic arms, play video games with their minds
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
Adjustable interatrial shunt for heart failure shows promise in first-in-human trial
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.
Beta-blockers do not benefit heart attack patients with a normal LVEF
The new meta-analysis included data from nearly 18,000 patients. Overall, patient outcomes were quite similar for patients who did and did not undergo beta-blocker therapy.
Drones deliver AEDs for the first time in the United States
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."
Early TAVR for asymptomatic severe AS cuts costs, improves outcomes
The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.

Poor oral health tied to much higher risk of heart attack, stroke

Regularly going to the dentist, researchers added, may reduce cardiovascular risks by a significant margin.

'The less you drink, the better': Even minor changes in alcohol use lower hypertension risk

These new findings challenge the long-standing assumption that low levels of alcohol do not meaningfully influence a person's blood pressure.

PCI for eruptive calcified nodules: Drug-eluting stents, drug-coated balloons both linked to poor outcomes

In some cases, researchers noted, CABG may be a better treatment option. The group emphasized that alternative therapies are still needed to improve patient care.

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM

No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

James Muller, MD, explains advances in vulnerable plaque imaging aim to predict and prevent heart attacks.

Advances in imaging could help predict, prevent heart attacks

Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.

Ismail El-Hamamsy, MD, PhD, director of aortic surgery for the Mount Sinai Health System, explains the long-term outcomes of the Ross procedure, where a diseased aortic valve is surgically replaced with the patient's own pulmonary valve.

Long-term data highlight Ross procedure's safety, effectiveness in younger patients

TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.

Three scientists share Nobel Prize in Medicine for discovering how the immune system is regulated

Mary E. Brunkow, PhD; Fred Ramsdell, PhD; and Shimon Sakaguchi, PhD, MD, will share the 2025 prize for research that has led to new treatments for autoimmune disease and cancer.

merger acquisition handshake deal business agreement partnership

RSNA readying ‘launchpad’ to help innovators take flight with fresh ideas

Ventures will serve as a hub for academic institutions, developers and industry leaders looking to drive meaningful innovation in radiology.

Clinical Research

Neuralink users reveal power to move robotic arms, play video games with their minds

Adjustable interatrial shunt for heart failure shows promise in first-in-human trial

Beta-blockers do not benefit heart attack patients with a normal LVEF

Drones deliver AEDs for the first time in the United States

Early TAVR for asymptomatic severe AS cuts costs, improves outcomes